KCNMA1 and myotonic dystrophy type 1: Taken together, these data suggest that the mechanism of reduced plasma membrane expression of KCa1.1 in DM1 myoblasts is not a result of defective protein trafficking but rather of alternative splicing or other modifications of KCa1.1, leading to its aberrant subcellular localization.